10-Q: Arcadia Biosciences Faces Going Concern Warning Amidst Q3 Losses

Arcadia Biosciences reported a net income from continuing operations for Q3 2025, but a significant credit loss and declining cash reserves raise substantial doubt about its ability to continue as a going concern.

Summary

• Arcadia Biosciences reported net income from continuing operations of $856,000 for the three months ended September 30, 2025, a significant improvement from a net loss of $1,182,000 in the prior year period.
• For the nine months ended September 30, 2025, the company recorded a net loss from continuing operations of $1,003,000, compared to a net loss of $280,000 in the same period of 2024.
• Product revenues decreased by 15% to $1,302,000 for the three months ended September 30, 2025, primarily due to the absence of GLA oil sales, which were present in 2024.
• Product revenues increased by 3% to $3,957,000 for the nine months ended September 30, 2025, driven by a 26% increase in Zola coconut water sales volume due to expanded distribution.
• The company recognized a credit loss of $4,745,000 for the nine months ended September 30, 2025, primarily due to establishing a reserve for the remaining $4,000,000 principal and accrued interest on a promissory note from Above Food Corp., which defaulted on its payment.
• Cash and cash equivalents decreased to $1,120,000 as of September 30, 2025, from $4,242,000 at December 31, 2024.
• The company received approximately 2.7 million shares of Above Food Ingredients, Inc. (AFII) common stock as a prepayment on the promissory note, recognizing an unrealized gain of $1,700,000 in other income for the quarter.
• The proposed merger with Roosevelt Resources LP is ongoing, with the registration statement on Form S-4 still under SEC review, and the termination date for the Exchange Agreement was extended to August 15, 2025.
• Arcadia transferred all rights and materials related to certain soy traits and its reduced gluten and oxidative stability patents to Bioceres Crop Solutions Corp. (BIOX) for $750,000, eliminating future product royalties.
• A $2,000,000 contingent liability related to the Anawah acquisition was eliminated due to the abandonment or transfer of remaining technologies.

Sentiment

Score: 2

Explanation: The company faces severe liquidity issues, evidenced by a going concern warning and a significant credit loss from a defaulted note. While Zola sales show growth, it's insufficient to offset overall losses and cash burn. The major strategic merger is delayed and faces legal challenges, adding to uncertainty. The reliance on potential future sales of volatile, restricted stock further highlights the precarious financial position.

Positives

• Net income from continuing operations for the three months ended September 30, 2025, was $856,000, a significant improvement from a $1,182,000 loss in the prior year.
• Zola coconut water sales increased by 26% for the nine months ended September 30, 2025, driven by increased distribution and sales volume.
• Selling, general, and administrative expenses decreased by $671,000 (30%) for the three months and $1,600,000 (22%) for the nine months ended September 30, 2025, reflecting reduced operating and employee-related costs.
• Research and development expenses decreased by 100% for the three months and 78% for the nine months ended September 30, 2025, aligning with a strategy to minimize new investment in the Zola brand.
• A gain of $2,000,000 was recognized from the elimination of a contingent liability related to the Anawah acquisition.
• The company received $750,000 from Bioceres Crop Solutions Corp. for the transfer of soy traits and patents, which had no carrying value, resulting in a gain.
• Net cash used in operating activities decreased to $3,878,000 for the nine months ended September 30, 2025, from $7,418,000 in the prior year period.

Negatives

• The company issued a going concern warning, stating that existing cash and cash equivalents of $1,120,000 are not sufficient to meet anticipated cash requirements for the next 12 months.
• Above Food Corp. defaulted on a $2,000,000 principal payment plus accrued interest on a promissory note, leading to a $4,745,000 credit loss reserve for the remaining principal and interest.
• Net loss from continuing operations for the nine months ended September 30, 2025, worsened to $1,003,000 from a $280,000 loss in the prior year period.
• Cash and cash equivalents significantly decreased to $1,120,000 as of September 30, 2025, from $4,242,000 at December 31, 2024.
• Total assets decreased to $8,584,000 as of September 30, 2025, from $13,517,000 at December 31, 2024.
• Interest income decreased by 97% for the three months and 48% for the nine months ended September 30, 2025, largely due to issues with the Above Food promissory note.
• The gain on sale of intangible assets was $750,000 for the nine months ended September 30, 2025, significantly lower than the $4,000,000 gain in the prior year from the sale of the RS durum wheat trait.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to insufficient cash and cash equivalents to meet anticipated requirements for the next 12 months.
• Above Food Corp.'s default on the promissory note means the company may not receive any cash payments, and recovery efforts are uncertain due to Above Food's involvement in bankruptcy/receivership proceedings.
• Uncertainty surrounds the liquidity and value of the Above Food Ingredients, Inc. (AFII) common stock received, including restrictions on resale under Rule 144, the need for 'current public information' about AFII, and market volatility.
• The company will require additional funding in the near term, and there are no assurances that such funding will be available on acceptable terms, potentially leading to dilution for stockholders or restrictive debt covenants.
• Failure to secure additional funding could force the company to reduce spending, extend payment terms, liquidate assets, or initiate dissolution/bankruptcy proceedings, which would materially harm the business.
• The ongoing merger with Roosevelt Resources LP is subject to SEC review and potential legal challenges from purported stockholders alleging deficiencies in the proxy statement, which could divert management time and incur significant legal fees.
• New U.S. government tariffs (10% baseline, 20% for Asian sourcing) are expected to increase the cost of goods sold for Zola coconut water, impacting profitability.
• The company is a defendant in a Proposition 65 lawsuit alleging BPA exposure in coconut water containers, which could result in injunctive relief, civil penalties, and significant legal costs.
• Future write-downs of inventory may be required if there are significant changes in demand and market conditions, materially increasing expenses.

Future Outlook

The company believes its existing cash and cash equivalents will not be sufficient to meet anticipated cash requirements for at least the next 12 months, raising substantial doubt about its ability to continue as a going concern. It will require additional funding in the near term, potentially through debt or equity financings or asset sales. The ability to sell shares of Above Food Ingredients, Inc. (AFII) is a potential source of funding, but is subject to resale restrictions, market volatility, and the need for AFII to meet public information requirements or file a registration statement. The proposed merger with Roosevelt Resources LP is ongoing, but the registration statement is still under SEC review, and the company faces legal challenges from purported stockholders regarding the proxy statement. Tariffs are expected to increase the cost of goods sold for Zola coconut water, and the full impact remains uncertain.

Management Comments

• "We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, which raises substantial doubt about the Company’s ability to continue as a going concern."
• "We will require additional funding in the near term to fund our business and the marketing and sale of our products and to provide working capital to fund other aspects of our business."
• "Arcadia believes that the six month holding period with respect to the Prepayment Shares initially issued should be satisfied by the end of calendar year 2025."
• "The Company intends to vigorously defend itself against the claims [Proposition 65 lawsuit]."
• "The Company believes that the allegations in the Demand Letters are without merit and intends to vigorously defend itself against any complaint that may be filed [Roosevelt merger]."

Industry Context

The company's primary continuing operation, Zola coconut water, operates in a seasonal beverage market, with sales typically highest in the second and third fiscal quarters. The imposition of new U.S. government tariffs (10% baseline, 20% for Asian sourcing) is a significant industry-wide challenge for companies sourcing internationally, expected to increase the cost of goods sold. The company's past activities in wheat traits and hemp reflect broader trends in agricultural biotechnology and specialty crops, with the winding down of the hemp joint venture due to regulatory challenges and market saturation highlighting the risks in emerging agricultural sectors.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• A complaint was filed on March 6, 2025, in California Superior Court by the Center for Environmental Health, alleging violations of Proposition 65 due to knowing and intentional exposure to Bisphenol A (BPA) in coconut water containers. The company intends to vigorously defend itself, but the outcome is uncertain.
• The company has received several demand letters from counsel to purported stockholders alleging deficiencies, material misstatements, and omissions in the preliminary proxy statement related to the Roosevelt Resources LP merger. These allegations include concerns about financial projections, fairness opinion analysis, potential conflicts of interest, and possible breach of fiduciary duties. The company believes these allegations are without merit and intends to vigorously defend itself against any potential complaints.

Related Party Transactions

• The company had royalty fees due to the John Sperling Foundation (JSF), a related party, for product sales related to intellectual property developed under research funding from Blue Horse Labs, Inc. (BHL). Royalty fees due to JSF were $0 as of September 30, 2025, and $30,000 as of December 31, 2024. These fees for 2024 sales were paid in April 2025, and no future royalty fees are expected as product sales related to this IP ceased as of December 31, 2024.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from potential future equity raises and the Roosevelt merger (existing shareholders to own 10% post-merger). The going concern warning and uncertainty around AFII stock value pose substantial risks to investment value. Legal challenges to the merger could further delay or jeopardize the transaction.
• **Employees**: Potential impact from cost reduction measures if additional funding is not secured, given the going concern warning. Stock-based compensation remains a component of employee incentives.
• **Customers**: May experience price increases for Zola coconut water due to new tariffs on imported goods.
• **Suppliers**: May face extended payment terms if the company's liquidity issues persist and additional funding is not secured.
• **Creditors**: The default on the Above Food promissory note highlights credit risk. In the event of dissolution or bankruptcy, creditors would have first claim on assets, with little to no value remaining for equity holders.

Next Steps

• Continue to pursue the business combination with Roosevelt Resources LP, awaiting SEC review and effectiveness of the Form S-4 registration statement.
• Vigorously defend against the Proposition 65 lawsuit regarding BPA in coconut water containers.
• Vigorously defend against any complaints arising from demand letters related to the Roosevelt merger proxy statement.
• Seek additional funding through debt or equity financings or sales of assets to address liquidity concerns.
• Monitor the tariff landscape and explore mitigation strategies with business partners to offset increased cost of goods sold.
• Evaluate the impact of new FASB accounting pronouncements on income tax disclosures and expense disaggregation.

Key Dates

Recommendation

The company explicitly states a 'substantial doubt' about its ability to continue as a going concern, a critical red flag for investors. This is compounded by a significant credit loss from a defaulted promissory note, severely impacting cash reserves. While Zola revenue shows some growth, it's insufficient to offset overall losses and the rapid decline in cash. The proposed merger, a key strategic pivot, is delayed and faces legal challenges, adding considerable uncertainty. The potential for significant shareholder dilution from future capital raises and the highly volatile and restricted nature of the AFII common stock further undermine the investment thesis. Given these severe financial and operational risks, a seasoned investor would likely recommend a strong sell.

Keywords

Arcadia Biosciences, RKDA, 10-Q, Quarterly Report, Going Concern, Zola Coconut Water, Above Food Corp, Promissory Note Default, AFII Common Stock, Roosevelt Resources LP Merger, SEC Filing, Financial Results, Liquidity, Credit Loss, Tariffs, Proposition 65, Bioceres Crop Solutions, Patent Sale